Close Menu
    Svizzera

    Per il CEO di Novartis, i prezzi della droga in Svizzera sono troppo bassi.


    Cosa ne pensi di questo articolo di The RTS (articolo in francese)?

    https://www.rts.ch/info/economie/2025/article/les-prix-des-medicaments-en-suisse-sont-trop-bas-estime-le-patron-de-novartis-29004298.html

    "Novartis mira a eliminare il divario di prezzo delle medicine tra gli Stati Uniti e altri paesi industrializzati. Il CEO del gruppo farmaceutico con sede a Basilea, Vas Narasimhan, ritiene che i paesi al di fuori degli Stati Uniti abbiano il dovere di contribuire maggiormente all’innovazione e ritiene che i prezzi siano troppo bassi in Svizzera."

    For the CEO of Novartis, drug prices in Switzerland are too low.
    byu/JonHaf inSwitzerland



    di JonHaf

    Share.
    View 15 Comments

    15 commenti

    1. Gnurx on

      He’s totally correct. 

      After I pay my health insurance, I still have some money for rent left. 

    3. cryingInSwiss on

      where the FUCK are the politicians

      yes yes I know lobbyism
      But how is it even possible that we don’t have even one politician with a conscience

    4. rainbow4enby on

      Perfect timing for the yearly KVG price shock… but SVP still thinks Trump is better for their country than the EU and a great and brilliant leader…

    5. Unusual-Context8482 on

      I think the interest rates on the CEO’s loans are too low.
      He clearly can afford more.

    6. Justiceenforcer4711 on

      Just buy a Novartis Share For each CHF You Spend ob drugs. 😜

    8. cheapcheap1 on

      And here we see why CEO salaries are so high: You couldn’t torture me into saying shit like that in Guantanamo.

    9. AutomaticAccount6832 on

      Let’s make a deal with big pharma. They can raise the prices as much as they want as long they pay double of it as additional taxes. So they can show the US how normal their prices are.

    10. wantonio2w on

      if they start raising prices, someone should petition the federal government to invalidate their patents and allow other enterprises to produce these pharmaceuticals. then we’ll see whether they still want to increase prices.

    11. Turicus on

      Lots of uninformed comments. In Switzerland, neither Novartis, nor its CEO can decide this. Prices are regulated by BAG.

    13. Basspayer on

      If he wants more contributions to innovation, he can start by reducing his 20 million salary

    14. Linkario86 on

      So are everyone’s salaries, except for top execs who get packages way beyond of what they deserve.

    Leave A Reply